Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | -18.62%8.83B | ---- | 2.34%17.44B | ---- | -0.54%10.85B | ---- | 11.84%17.05B | ---- | 23.28%10.91B |
| Profit adjustment | ||||||||||
| Investment loss (gain) | ---- | -18.97%-1.27B | ---- | -20.49%-1.93B | ---- | -10.18%-1.07B | ---- | 4.40%-1.6B | ---- | -40.38%-970.78M |
| Impairment and provisions: | ---- | -14.02%4.56M | ---- | -63.41%125.35M | ---- | -91.17%5.3M | ---- | 126.55%342.62M | ---- | 26.20%59.98M |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 26.18%59.97M |
| Revaluation surplus: | ---- | -5,530.44%-29.86M | ---- | -34.43%6.32M | ---- | -88.52%549.92K | ---- | 117.36%9.64M | ---- | 108.17%4.79M |
| Asset sale loss (gain): | ---- | -150.18%-17.8M | ---- | -192.53%-11.39M | ---- | -135.85%-7.12M | ---- | 37.49%-3.89M | ---- | -39.63%-3.02M |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -150.18%-17.8M | ---- | -192.53%-11.39M | ---- | -135.85%-7.12M | ---- | 37.49%-3.89M | ---- | -39.63%-3.02M |
| Depreciation and amortization: | ---- | 8.88%6.77B | ---- | 9.94%13.5B | ---- | 8.86%6.22B | ---- | 14.28%12.28B | ---- | 10.20%5.71B |
| -Amortization of intangible assets | ---- | 43.29%375.25M | ---- | 13.72%650.73M | ---- | -5.02%261.87M | ---- | 5.00%572.22M | ---- | 2.38%275.7M |
| -Other depreciation and amortization | ---- | 0.91%25.29M | ---- | 10.15%52.43M | ---- | 6.67%25.07M | ---- | 20.70%47.6M | ---- | 19.51%23.5M |
| Financial expense | ---- | -9.23%2.39B | ---- | -9.13%5.39B | ---- | -14.42%2.64B | ---- | -12.32%5.93B | ---- | -5.08%3.08B |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -191.71%-814.61M | ---- | 105.00%145.47M | ---- | 336.67%888.2M | ---- | -14.04%-2.91B | ---- | -205.81%-375.29M |
| Accounts receivable (increase)decrease | ---- | 442.88%1.03B | ---- | -121.10%-425.74M | ---- | -158.14%-301.21M | ---- | 182.50%2.02B | ---- | 138.28%518.06M |
| Accounts payable increase (decrease) | ---- | 0.90%-4.86B | ---- | -274.26%-559.12M | ---- | -67.14%-4.91B | ---- | -94.69%320.86M | ---- | -26.54%-2.94B |
| Special items of business | ---- | 52.88%-720.67M | ---- | 1,508.78%4.34B | ---- | -371.95%-1.53B | ---- | 63.10%-307.84M | ---- | -0.51%-324.04M |
| Adjustment items of business operations | -19.47%20.79B | -15.93%12.04B | -64.88%1.96B | 0.75%33.68B | -4.36%25.82B | -10.53%14.32B | 25.19%5.58B | 3.80%33.43B | 10.97%27B | 20.70%16B |
| Net cash from operations | -19.47%20.79B | -11.51%11.32B | -64.88%1.96B | 14.78%38.02B | -4.36%25.82B | -18.44%12.79B | 25.19%5.58B | 5.58%33.12B | 10.97%27B | 21.21%15.68B |
| Cash flow from investment activities | ||||||||||
| Dividend received - investment | 73.14%1.3B | 1,474.09%330.6M | --295.44M | -43.70%938.87M | -32.68%750.6M | -92.74%21M | --0 | 82.25%1.67B | 60.48%1.12B | 1,261.37%289.31M |
| Sale of fixed assets | 533.30%415.95M | 377.27%229.38M | -73.98%6.62M | 427.40%71.82M | 620.61%65.68M | 441.03%48.06M | 204.19%25.45M | -73.34%13.62M | -77.67%9.11M | 700.04%8.88M |
| Purchase of fixed assets | -73.28%-16.67B | -74.82%-10.89B | -53.15%-5.11B | -38.05%-19.67B | -6.86%-9.62B | -7.15%-6.23B | -1.52%-3.34B | -20.32%-14.25B | -25.40%-9B | -36.88%-5.81B |
| Sale of subsidiaries | --2.25M | --2.25M | --2.25M | --91.21M | --0 | ---- | --0 | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---1.2B | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash on investment | 30.22%-195M | 58.99%-90M | --0 | 26.81%-537.48M | -365.74%-279.45M | -265.74%-219.45M | -264.23%-218.54M | 15.56%-734.4M | 92.59%-60M | 92.59%-60M |
| Other items in the investment business | 759.45%892.9M | 15.68%1.6B | 8.50%1.12B | -235.68%-1.07B | -120.28%-135.4M | -31.77%1.39B | -24.48%1.03B | 129.28%786.7M | 222.59%667.51M | 230.23%2.03B |
| Net cash from investment operations | -54.62%-14.25B | -76.52%-8.81B | -95.84%-4.89B | -61.19%-20.17B | -26.80%-9.22B | -40.95%-4.99B | -47.04%-2.5B | 12.98%-12.51B | -3.95%-7.27B | 19.84%-3.54B |
| Net cash before financing | -60.62%6.54B | -67.86%2.51B | -194.74%-2.93B | -13.40%17.85B | -15.84%16.6B | -35.76%7.8B | 11.77%3.09B | 21.30%20.61B | 13.80%19.73B | 42.49%12.14B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 13.05%81.58B | 21.45%61.61B | 71.40%35.97B | 53.13%93.78B | 40.58%72.16B | 35.89%50.73B | 11.00%20.99B | -21.89%61.24B | -15.73%51.33B | -19.99%37.33B |
| Refund | 15.28%-59.75B | -7.15%-51.76B | -65.01%-28.19B | -53.24%-95.51B | -30.51%-70.52B | -20.34%-48.31B | -5.45%-17.08B | 24.45%-62.33B | 15.77%-54.03B | 13.24%-40.14B |
| Dividends paid - financing | -9.17%-14.47B | -7.83%-5.79B | -15.49%-2.67B | 8.00%-16.04B | 3.50%-13.25B | -7.32%-5.37B | 0.30%-2.31B | -3.57%-17.43B | -4.11%-13.74B | 3.65%-5.01B |
| Absorb investment income | 90.06%185.5M | ---- | ---- | 19.43%101.93M | 25.13%97.6M | ---- | ---- | -78.89%85.35M | -64.42%78M | ---- |
| Other items of the financing business | -509.08%-1.48B | -655.46%-1.4B | 49.35%-52.06M | 53.08%-309.07M | 28.54%-242.29M | 32.27%-185.21M | -61.90%-102.79M | -73.96%-658.73M | -42.44%-339.04M | -89.38%-273.46M |
| Net cash from financing operations | 151.62%6.07B | 184.66%2.66B | 240.02%5.06B | 5.84%-17.97B | 29.58%-11.76B | 61.23%-3.14B | 360.68%1.49B | 8.65%-19.09B | -1.54%-16.7B | -63.41%-8.09B |
| Effect of rate | 31.77%19.23M | -500.86%-48.68M | 220.97%6.41M | -40.34%12.52M | -19.54%14.59M | -70.97%12.14M | -96.25%2M | 119.64%20.99M | 140.56%18.14M | 276.87%41.83M |
| Net Cash | 160.42%12.61B | 10.77%5.16B | -53.39%2.13B | -108.32%-126.46M | 59.94%4.84B | 15.16%4.66B | 48.28%4.58B | 138.88%1.52B | 240.77%3.03B | 13.46%4.05B |
| Begining period cash | -1.45%9B | -1.45%9B | -1.45%9B | 20.38%9.1B | 20.85%9.13B | 20.85%9.13B | 20.85%9.13B | -34.69%7.56B | -34.69%7.56B | -34.69%7.56B |
| Cash at the end | 54.60%21.63B | 2.23%14.11B | -18.76%11.14B | -1.25%8.98B | 31.94%13.99B | 18.55%13.81B | 28.18%13.71B | 20.38%9.1B | -14.60%10.6B | -22.95%11.65B |
| Cash balance analysis | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
| Auditor | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- | -- | KPMG Huazhen Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.